Market Cap (In AUD)
16.32 Million
Revenue (In AUD)
152.24 Thousand
Net Income (In AUD)
-4.13 Million
Avg. Volume
295.77 Thousand
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.185-0.5
- PE
- -
- EPS
- -
- Beta Value
- 0.476
- ISIN
- AU0000180887
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Tony Charara
- Employee Count
- -
- Website
- https://www.tissuerepair.com.au
- Ipo Date
- 2021-11-17
- Details
- Tissue Repair Ltd, a clinical stage biopharmaceutical company, developing advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987 and other dressing/matrices, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures, as well as other products for veterinary, new bandage, scaffold products, and other therapeutic indications. The company was incorporated in 2012 and is headquartered in Sydney, Australia.
More Stocks
-
SAMYAKINTSamyak International Limited
SAMYAKINT
-
0OPJABC arbitrage SA
0OPJ
-
KTBSTMR
-
ARFArena REIT
ARF
-
MENEMene Inc.
MENE
-
NEWT
-
SWPRFSwiss Prime Site AG
SWPRF
-
REXSEALRex Sealing and Packing Indust
REXSEAL